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Results 
Recommendations 
• Vermont CARES should expand its services to include 
patients with HCV. 
 
• State and federal government should expand funding for 
HCV treatment in order to support these services. 
 
• Vermont CARES should investigate barriers to patients 
pursuing HCV treatment in Vermont including: 
• Access to expensive treatments 
• Exclusion criteria based on IVDU 
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• It is likely Vermont CARES 
case management of active 
IV drug users and others 
with HCV would result in 
their successful treatment 
and a reduced community 




• Our sample’s proportion of HCV acquisition from IVDU is 
similar to the national figures (58% vs. 60%)7. 
 
• Respondents are well-connected to the healthcare system. 
 
• Most respondents (77%) feel that at least one service 
currently offered by Vermont CARES would be very helpful 
to them. In addition, patients with HCV are comfortable 
receiving services from Vermont CARES, with only 4% 
reporting discomfort. This makes Vermont CARES a very 
appropriate organization for patients seeking HCV-related 
support services. 
 
• 75% of respondents reported not currently pursuing HCV 
treatment. Respondents with case managers are three times 
more likely to be getting treatment than those without case 
managers. Expanding case management at Vermont CARES 
could improve treatment rates. 
 
 
• A total of 48 surveys were collected from clinics, needle exchanges, and 
case management facilities across the state of Vermont.  
 
• The average annual income of all respondents is $15,000 +/- $7,700 with 
a male to female ratio of 1.6:1 and an age range from 18-60+.  
 
• 62% of all respondents report having had HCV for 6 or more years. 
 
• 47 out of 48 report having health insurance, with 90% having coverage 
by Medicare/Medicaid, and 90% having a primary care physician.  
 
*Not significant after modified Bonforroni correction. 
**No significant differences in degree of comfort among these groups. 
Methods 
• Conducted a literature review and 
consulted Vermont experts on HCV 
• Distributed a 20-question survey to 
seven sites across the state over a 
six-week period to identify the 
demographics and needs of 
Vermonters with HCV (Figure 1) 
• Data were compiled into Microsoft 
Excel, and analyzed graphically and 
using VassarStats with non-
parametric statistical methods. 
Objectives 
• What are the demographics of the most resource-limited 
HCV positive population in Vermont? 
 
• Does expanding the model of care for patients with HIV at 
Vermont CARES appeal to patients with HCV? 
 
• Are patients with HCV comfortable receiving services 
from Vermont CARES? 
 
• Would expanding Vermont CARES case management to 
include patients with HCV improve their access to care? 
Background 
Hepatitis C (HCV) 
• Viral infection of the liver spread primarily via blood-to-
blood contact (e.g., intravenous drug use (IVDU)) 
• United States: 3.2 million chronic HCV infections (2010)1 
• Vermont: 1.63 cases per 1000 people (2012-2013)2 
Barriers to Care 
• Exclusion of current IV drug users from HCV treatment 
programs despite their high rates of infection3 
• Lack of support, causing decreased treatment adherence4 
• Poor access to treatment: cost, transportation, competing 
priorities of housing, addiction management, and food5 
HIV and HCV 
• Research has shown that the multidisciplinary and 
integrated HIV model is appropriate for HCV6 
Vermont CARES  
• Non-profit organization that provides comprehensive 
services to clients with HIV in Vermont 
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FIGURE 5 





































Case manager helping you get HCV care? 
FIGURE 4 
CARE ACCESSED (PAST 12 MONTHS) 
FIGURE 3 
HOW DID YOU ACQUIRE HEPATITIS C? 
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